QuickView for non- nucleoside reverse transcriptase inhibitors

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. Broad Connectivity Map (CMAP 2.0) compound database
4. Drug target sets for approved compounds
5. Drug Matrix In Vitro Toxicogenomic Study - Rat Hepatocytes [Affymetrix]

There were no matches for non- nucleoside reverse transcriptase inhibitors

1. Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HI…
2. Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors
3. Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-N…
4. A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retr…
5. Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and…